{
  "cik": 1600620,
  "cik_padded": "0001600620",
  "entityName": "Aurinia Pharmaceuticals Inc.",
  "fiscal_years": [
    {
      "accn": "0001600620-26-000017",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 98156000.0,
        "cash": 80160000.0,
        "eps_diluted": 2.07,
        "net_income": 287202000.0,
        "operating_cash_flow": 135658000.0,
        "operating_income": 104914000.0,
        "stockholders_equity": 581331000.0,
        "total_assets": 751587000.0,
        "total_liabilities": 170256000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.2928727351543269,
        "roa_avg2y": 0.4410919098900964,
        "roa_period_end": 0.3821274183827022,
        "roe_avg2y": 0.5990807345362841,
        "roe_period_end": 0.494042120581906
      }
    },
    {
      "accn": "0001600620-26-000017",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 40239000.0,
        "cash": 83396000.0,
        "eps_diluted": 0.04,
        "net_income": 5752000.0,
        "operating_cash_flow": 44388000.0,
        "operating_income": -4687000.0,
        "stockholders_equity": 377478000.0,
        "total_assets": 550645000.0,
        "total_liabilities": 173167000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.45874726474125643,
        "roa_avg2y": 0.010470489402543172,
        "roa_period_end": 0.010445931589317982,
        "roe_avg2y": 0.01522837263976109,
        "roe_period_end": 0.015237974133591892
      }
    },
    {
      "accn": "0001600620-26-000017",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 0.0,
        "cash": 48755000.0,
        "eps_diluted": -0.54,
        "net_income": -78020000.0,
        "operating_cash_flow": -33461000.0,
        "operating_income": -91691000.0,
        "stockholders_equity": 377954000.0,
        "total_assets": 548062000.0,
        "total_liabilities": 170108000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4500759351667134,
        "roa_avg2y": -0.1531422424876487,
        "roa_period_end": -0.14235615678518124,
        "roe_avg2y": -0.19918584509100842,
        "roe_period_end": -0.20642723717701095
      }
    },
    {
      "accn": "0001600620-26-000017",
      "filed": "2026-02-26",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 0.0,
        "cash": 94088000.0,
        "eps_diluted": -0.76,
        "net_income": -108180000.0,
        "operating_cash_flow": -79529000.0,
        "operating_income": -111470000.0,
        "stockholders_equity": 405435000.0,
        "total_assets": 470860000.0,
        "total_liabilities": 65425000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.16136988666494012,
        "roa_avg2y": -0.21332502487115804,
        "roa_period_end": -0.22974981947925074,
        "roe_avg2y": -0.24460558536436464,
        "roe_period_end": -0.2668245218099079
      }
    },
    {
      "accn": "0001628280-23-005341",
      "filed": "2025-02-27",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 231643000.0,
        "eps_diluted": -1.4,
        "net_income": -180966000.0,
        "operating_cash_flow": -157692000.0,
        "operating_income": -180735000.0,
        "stockholders_equity": 479091000.0,
        "total_assets": 543367000.0,
        "total_liabilities": 64276000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1341624033847432,
        "roa_avg2y": -0.3594060939715678,
        "roa_period_end": -0.3330456210995515,
        "roe_avg2y": -0.4081137430497688,
        "roe_period_end": -0.37772782206303185
      }
    },
    {
      "accn": "0001628280-23-005341",
      "filed": "2024-02-15",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 272350000.0,
        "eps_diluted": -0.87,
        "net_income": -102680000.0,
        "operating_cash_flow": -69858000.0,
        "operating_income": -104290000.0,
        "stockholders_equity": 407750000.0,
        "total_assets": 463661000.0,
        "total_liabilities": 55911000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.13712078479460454,
        "roa_avg2y": -0.26062170510760674,
        "roa_period_end": -0.22145489916124064,
        "roe_avg2y": -0.29073405535499397,
        "roe_period_end": -0.25182096873084
      }
    },
    {
      "accn": "0001628280-23-005341",
      "filed": "2023-02-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 306019000.0,
        "eps_diluted": -0.95,
        "net_income": -88385000.0,
        "operating_cash_flow": -63585000.0,
        "operating_income": -90943000.0,
        "stockholders_equity": 298600000.0,
        "total_assets": 324301000.0,
        "total_liabilities": 25701000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.08607166778298728,
        "roa_period_end": -0.2725400168362108,
        "roe_avg2y": -0.4070068636502831,
        "roe_period_end": -0.2959979906229069
      }
    },
    {
      "accn": "0001628280-22-004082",
      "filed": "2022-02-28",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "net_income": -53079000.0,
        "operating_cash_flow": -51611000.0,
        "operating_income": -55240000.0,
        "stockholders_equity": 135717000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roe_avg2y": -0.3384719374822646,
        "roe_period_end": -0.39110059904065075
      }
    },
    {
      "accn": "0001628280-21-003060",
      "filed": "2021-02-24",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": 177922000.0
      },
      "period_end": "2017-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001600620-26-000017",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001600620.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001600620.json"
  },
  "ticker": "AUPH"
}